Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 39 | 01/05/14 | |
President | - | - | |
Anthony Sireci
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Liz Beja
COO | Chief Operating Officer | - | - |
David Hyman
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Compliance Officer | - | 01/04/18 | |
Human Resources Officer | - | - | |
Amy Rose
HRO | Human Resources Officer | - | 01/01/20 |
Philip Johnson
LAW | General Counsel | - | 01/11/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 30 614 536 | 29 481 314 ( 96,30 %) | 0 | 96,30 % |
Coordinate società
Loxo Oncology, Inc.
281 Tresser Boulevard 9th floor
06901, Stamford
+203-653-3880
http://www.loxooncology.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
-1,76% | 103 Mrd | |
+7,24% | 101 Mrd | |
+4,40% | 23,07 Mrd | |
-11,99% | 22,23 Mrd | |
-4,36% | 18,05 Mrd | |
-39,98% | 17,18 Mrd | |
-10,76% | 16,94 Mrd | |
+6,20% | 14,07 Mrd | |
+37,77% | 12,35 Mrd |